# The Adult Hemorrhagic Moyamoya Surgery Study

Study · id `cardio:ct-nct02319980` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02319980](<https://clinicaltrials.gov/study/NCT02319980>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02319980

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.

## Technical summary

Registry record NCT02319980. Randomized; single masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2023-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 360 participants (planned count; ClinicalTrials.gov record NCT02319980, source copy `cardio:ctgov-nct02319980-2016-02-17`, retrieved 2026-10-26)
- Start date: 2015-05 (registry gives no type) (ClinicalTrials.gov record NCT02319980, source copy `cardio:ctgov-nct02319980-2016-02-17`, retrieved 2026-10-26)
- Primary completion: 2023-05 (anticipated) (ClinicalTrials.gov record NCT02319980, source copy `cardio:ctgov-nct02319980-2016-02-17`, retrieved 2026-10-26)
- Completion: 2023-05 (anticipated) (ClinicalTrials.gov record NCT02319980, source copy `cardio:ctgov-nct02319980-2016-02-17`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02319980, source copy `cardio:ctgov-nct02319980-2016-02-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02319980-2016-02-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Adult Hemorrhagic Moyamoya Surgery Study
- Acronym: AHMSS
- Condition: Moyamoya
- Condition: Stroke
- Intervention (Procedure): Extracranial-intracranial bypass surgery
- Lead sponsor: Huashan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Moyamoya disease (`cardio:moyamoya-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Huashan Hospital (`cardio:org-huashan-hospital`)

## Provenance

Content hash: 4544a39dbf44ee51da5109c30ea16ed36e556c64b900533646a0b1b9e2a7716a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
